Research summary, narrative review, 2025

Radiation in the Orthopedic Operating Room: What We Know, What We Do, and What Needs Attention

Hamid MA, Younis Z, Raza A, Tauseef A, Khan MAH, Mir S, et al.. Cureus. 2025

Read the original paper

In plain language

This narrative review of orthopedic operating room radiation finds that aprons, thyroid shields, lead glasses, pulsed fluoroscopy and distance substantially lower staff dose, but training and personal protective equipment (PPE) use are inconsistent; possible breast cancer risk in female surgeons needs further study.

At a glance

Type of study
Narrative review
Who was studied
Orthopedic surgeons, Other surgeons, Radiologic technologists, Trainees, Mixed lab staff
Summary based on
the full text

What it found

  • Lead aprons of 0.25 and 0.5 mm lead equivalence attenuate most scatter radiation.

    Key figures: up to 90% and 97%

  • Standard aprons may not adequately shield the upper outer quadrant of the breast; lead sleeves and axillary supplements reduced breast exposure compared with a vest alone.

  • Lead glasses reduced eye dose about tenfold in hip surgeons.

    Key figures: 10 times

  • Pulsed and low-dose modes reduced average radiation exposure time in spinal interventions.

    Key figures: 56.7% reduction; 316 patients

  • Many orthopedic surgeons lack radiation safety training and as low as reasonably achievable (ALARA) awareness, per a cited South African survey.

    Key figures: 73% untrained; 77% unaware of ALARA

Limits to keep in mind

Narrative review without systematic search, risk-of-bias assessment or meta-analysis; cited figures come from heterogeneous primary studies, and breast cancer concerns rest on emerging observational evidence.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.